A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia

Bulletin of the World Health Organization

Volumn 82, Issue 5, 2004, Pages 364-372

  Fucharoen, Goonnapa ^a   Sanchaisuriya, Kanokwan ^a   Sae Ung, Nattaya ^a   Dangwibul, Samrit ^b   Fucharoen, Supan ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Kasetwisai Hospital   (Thailand)

Author keywords

2,6 Dichloroindophenol diagnostic use; Cambodia; Carrier state blood; Erythrocyte indices; Hemoglobin E diagnostic use; Lao People's Democratic Republic; Osmotic fragility; Precipitin tests; Rural population; Thailand; Thalassemia diagnosis blood

Indexed keywords

2,6 DICHLOROPHENOLINDOPHENOL; ALPHA GLOBIN; BETA GLOBIN; HEMOGLOBIN E;

BLOOD; HEALTH MONITORING; HEMOGLOBIN; MONITORING SYSTEM; RURAL POPULATION;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD GROUP TYPING; COMMUNITY CARE; CONTROLLED STUDY; ELECTRONICS; ERYTHROCYTE; EVALUATION; HEMOGLOBIN DETERMINATION; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; OSMOTIC FRAGILITY; POLYMERASE CHAIN REACTION; PRECIPITATION; PREDICTION; QUANTITATIVE ASSAY; RESOURCE ALLOCATION; RURAL AREA; SCHOOL CHILD; SCREENING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SOUTHEAST ASIA; STATISTICAL SIGNIFICANCE; THALASSEMIA;

2,6-DICHLOROINDOPHENOL; ADOLESCENT; ADULT; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENOTYPE; HEMOGLOBIN E; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; PREVALENCE; PRIMARY HEALTH CARE; PROGRAM DEVELOPMENT; REAGENT KITS, DIAGNOSTIC; RURAL HEALTH; SENSITIVITY AND SPECIFICITY; THAILAND; THALASSEMIA;

EID: 2642525357     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization 2001;79:704-12.
2. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987;11:65-88.
3. Na-Nakorn S, Wasi P. The distribution of hemoglobin E: hemoglobin E triangle in Southeast Asia. Journal of the Medical Association of Thailand 1972;61:65-8.
4. E-globin gene among eight minority groups of Northeast Thailand. Human Heredity 2002;53:18-22.
5. Fucharoen S, Winichagoon P. Thalassemia in Southeast Asia: problem and strategy for prevention and control. Southeast Asian Journal of Tropical Medicine and Public Health 1992;23:647-55.
6. Fucharoen S, Winichagoon P, Thonglairoam V, Siriboon W, Sirithanaratkul N, Kanokpongsakde S, et al. Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: experience from 100 pregnancies. Southeast Asian Journal of Tropical Medicine and Public Health 1991;22:16-29.
7. The thalassemia working party of the BCSH general haematology task force. Guidelines for investigation of the α- and β-thalassaemia traits. Journal of Clinical Pathology 1994;47:289-95.
8. A Working Party of the General Haematology Task Force of the British Committee for Standards in Haematology. The laboratory diagnosis of haemoglobinopathies. British Journal of Haematology 1998; 101:783-92.
9. Silvestroni E, Bianco I. A highly cost effective method of mass screening for thalassaemia. BMJ 1983;286:1007-9.
10. Kattamis C, Efremov G, Pootrakul S. Effectiveness of one tube osmotic fragility test screening in detecting β-thalassaemia trait. Journal of Medical Genetics 1981;18:266-70.
11. Frischer H, Bowman JE. Hemoglobin E an oxidatively unstable mutation. Journal of Laboratory and Clinical Medicine 1975;35:531-9.
12. Fucharoen G, Kanta K, Pratumchat R, Yimprasert U, Paikapet K, Surin U et al. Thalassemia and iron deficiency among OF-test and KKU-DCIP-Clear screening positive population. [In Thai.] Thai Journal of Hematology and Transfusion Medicine 1999;9:111-8.
13. Panyasai S, Sringam P, Fucharoen G, Sanchaisuriya K, Fucharoen S. A simplified screening for α-thalassemia 1 (SEA type) using a combination of a modified osmotic fragility test and a direct PCR on whole blood cell lysates. Acta Haematologica 2002;108:74-8.
14. Fucharoen G, Fucharoen S. Rapid and simultaneous non-radioactive method for detecting α-thalassemia 1 (SEA type) and Hb Constant Spring genes. European Journal of Haematology 1994;53:186-7.
15. 2 level: implication for population screening. Annals of Clinical Biochemistry 2002;39:44-9.
16. Fucharoen S, Fucharoen G, Sriroongreung W, Laosombat V, Jetsrisuparb A, Prasatkaew S, et al. Molecular basis of β-thalassemia in Thailand: analysis of β-globin gene mutations using the polymerase chain reaction. Human Genetics 1989;84:41-6.
17. Siriratmanawong N, Fucharoen G, Sanchaisuriya K, Ratanasiri T, Fucharoen S. Simultaneous PCR detection of β-thalassemia and α-thalassemia 1 (SEA type) in prenatal diagnosis of complex thalassemia syndrome. Clinical Biochemistry 2001;34:377-80.
18. Sanchaisuriya K, Fucharoen G, Sae-ung N, Sae-ue N, Baisungneon R, Jetsrisuparb A, et al. Molecular and hematological characterization of Hb E heterozygote with α-thalassemia determinant. Southeast Asian Journal of Tropical Medicine and Public Health 1997;28 Suppl 1:100-3.
19. Stein J, Berg C, Jones JA, Detter JC. A screening protocol for a prenatal population at risk for inherited hemoglobin disorders: results of its application to a group of Southeast Asians and blacks. American Journal of Obstetrics and Gynecology 1984;150:333-41.
20. Cao A, Galanello R, Rosatelli MC. Prenatal diagnosis and screening of the haemoglobinopathies. Baillière's Clinical Haematology 1998;11:215-38.
21. Ma ESK, Chan AYY, Ha SY, Lau YL, Chan LC. Thalassemia screening on red cell indicies in the Chinese. Haematologica 2001;86:1310-1.
22. Chan LC, Ma SK, Chan AYY, HA SY, Waye JS, Lau YL, et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fl in areas with a high prevalence of thalassemia? Journal of Clinical Pathology 2001;54:317-20.
23. Thool AA, Walde MS, Shrikhande AV, Talib VH. A simple screening test for the detection of heterozygous beta thalassemia. Indian Journal of Pathology and Microbiology 1998;41:423-6.
24. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. Prevention and control of haemoglobinopathies. Bulletin of the World Health Organization 1995;73:375-86.